Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NBP607 immunogenicity and safety in healthy adults
NCT02344134Phase 3Completed
- Sponsor
- SK Chemicals
- Start
- Sep 2013
- Primary completion
- Nov 2013
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 3 trial of NBP607-V in influenza, sponsored by SK Chemicals. Started Sep 2013; status: completed.
02
Drugs
NBP607-V
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02344134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02344134.